Impact of Coronavirus Disease Diagnosis on Maternal and Neonatal Health Outcomes in Pregnancy: Two Case Reports

Abstract

The new coronavirus, named severe acute respiratory syndrome coronavirus 2, is a major public health problem. When exposed to infection, alterations in the immune system, decreased respiratory capacity, and vascular and hemodynamic changes put pregnant women at high risk of complications. The fetus/newborn may be harmed. This study aimed to determine the maternal and neonatal outcomes of 2 pregnant women diagnosed with coronavirus disease 2019 (COVID-19). These 2 cases contribute to the growing evidence of the potential adverse maternal and neonatal outcomes of (COVID-19) infection during pregnancy.

Keywords

• Coronaviras disease 2019
• pregnant woman
• neonates
• preterm birth
• preeclampsia

References

1. 1. Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054.
2. 2. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19 : A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823-829. [CrossRef]
3. 3. Dileep A, ZainAlAbdin S, AbuRuz S. Investigating the association between severity of COVID-19 infection during pregnancy and neonatal outcomes. Sci Rep. 2022;12(1):3024. [CrossRef]
4. 4. Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without Covid-19 infection the intercovid multinational cohort study. JAMA Pediatr. 2021;175(8):817-826. [CrossRef]
5. 5. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51- 60. [CrossRef]
6. 6. World Health Organization. Coronavirus disease (COVID-19): pregnancy, childbirth and the postnatal period. 2022. Available at: https ://www.who.int/news-room/questions-and answers/item/coronavi rus-disease-covid-19-pregnancy-and-childbirth Accessed December 10, 2022.
7. 7. Qiao J. What are the risks of COVID-19 infection in pregnant women ? Lancet. 2020;395(10226):760-762. [CrossRef]
8. 8. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of sars-cov-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-1567. [CrossRef]

9. 9. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-815. [CrossRef]
10. 10. Zeng L, Xia S, Yuan W, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020;174(7):722-725. [CrossRef]
11. 11. Sisman J, Jaleel MA, Moreno W, et al. Intrauterine transmission of SARS-COV-2 infection in a preterm infant. Pediatr Infect Dis J. 2020;39(9):e265-e267. [CrossRef]
12. 12. Algarroba GN, Rekawek P, Vahanian SA, et al. Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy. Am J Obstet Gynecol. 2020;223(2):275-278. [CrossRef]
13. 13. Khedmat L, Mohaghegh P, Veysizadeh M, Hosseinkhani A, Fayazi S, Mirzadeh M. Pregnant women and infants against the infection risk of COVID-19: a review of prenatal and postnatal symptoms, clinical diagnosis, adverse maternal and neonatal outcomes, and available treatments. Arch Gynecol Obstet. 2022;306(2):323-335. [CrossRef]
14. 14. Centers for disease control and prevention. COVID-19 during pregnancy [internet]. 2022. Available at: https://www.cdc.gov/brfss/brfs sprevalence/ Accessed December 10, 2022.